Loading insider details...
Beta
Latest Form 4 (Aug 4, 2026): Grant/Award of 50,000 INTI shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 4, 2026 | Inhibitor Therapeutics, Inc. (INTI) | Grant/Award | 50,000 | n/a |
| Apr 7, 2025 | Inhibitor Therapeutics, Inc. (INTI) | Grant/Award | 50,000 | n/a |
| Dec 10, 2024 | MIRA PHARMACEUTICALS, INC. (MIRA) | Grant/Award | 150,000 | n/a |
| Sep 4, 2024 | Telomir Pharmaceuticals, Inc. (TELO) | Grant/Award | 200,000 | n/a |
| May 16, 2024 | Inhibitor Therapeutics, Inc. (INTI) | Grant/Award | 50,000 | n/a |
| Mar 27, 2024 | MIRA PHARMACEUTICALS, INC. (MIRA) | Grant/Award | 150,000 | n/a |
| Aug 21, 2023 | MIRA PHARMACEUTICALS, INC. (MIRA) | Grant/Award | 20,000 | n/a |
| May 17, 2023 | Inhibitor Therapeutics, Inc. (INTI) | Other (see footnotes) | 796,271 | n/a |